Kura Oncology Ownership | Who Owns Kura Oncology?

Overview Forecast RevenueFinancials Chart Transcripts

Kura Oncology Ownership Summary

Kura Oncology is owned by 92.04% institutional investors, 1.09% insiders, and 6.87% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.12% of KURA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.18% of its assets in Kura Oncology shares.

KURA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Kura Oncology	92.04%	1.09%	6.87%
Sector	Healthcare Stocks	279.19%	10.62%	-189.81%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	7.93M	9.12%	$69.11M
Blackrock	6.97M	8.30%	$143.43M
Armistice capital	5.80M	6.67%	$50.52M
Suvretta capital management	5.08M	5.84%	$44.22M
Vanguard group	4.82M	5.54%	$41.97M
Ra capital management	4.45M	5.12%	$38.77M
Ecor1 capital	3.56M	4.09%	$30.98M
State street	2.88M	3.44%	$59.39M
Bvf inc/il	2.57M	2.95%	$22.36M
Millennium management	2.37M	2.72%	$20.62M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Foresite capital management iv	1.73M	13.82%	$15.04M
Alethea capital management	558.44K	4.16%	$4.86M
Prosight management, lp	629.90K	3.88%	$12.97M
Suvretta capital management	5.08M	1.51%	$44.22M
1492 capital management	342.60K	1.42%	$2.98M
Tcg crossover management	1.42M	1.21%	$12.40M
Ecor1 capital	3.56M	1.17%	$30.98M
Boxer capital	1.00M	1.08%	$20.59M
Dafna capital management	448.37K	0.99%	$3.91M
Sphera funds management	610.09K	0.96%	$5.31M

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	4.45M	0.52%	4.45M
Armistice capital	5.80M	0.69%	3.14M
Millennium management	2.37M	0.01%	1.52M
Qube research	1.12M	0.01%	1.01M
Marshall wace, llp	948.90K	0.01%	948.90K

Top Sellers

Holder	Shares	% Assets	Change
Deerfield management company, l.p. (series c)	-	-	-5.41M
Paradigm biocapital advisors lp	-	-	-4.33M
Suvretta capital management	5.08M	1.51%	-2.58M
Avoro capital advisors	-	-	-2.25M
Ecor1 capital	3.56M	1.17%	-2.25M

New Positions

Holder	Shares	% Assets	Change	Value
Ra capital management	4.45M	0.52%	4.45M	$38.77M
Voss capital	275.00K	0.18%	275.00K	$2.40M
Gsa capital partners llp	89.31K	0.06%	89.31K	$778.00K
Jennison associates	71.50K	0.00%	71.50K	$622.74K
Nebula research & development	63.87K	0.07%	63.87K	$556.27K

Sold Out

Holder	Change
National bank of canada /fi/	-1.00
Ifp advisors	-9.00
Quantbot technologies lp	-14.00
Nelson, van denburg & campbell wealth management group	-14.00
Massmutual trust co fsb/adv	-19.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	187	-1.06%	80,458,625	1.94%	92	1.12%	97	-19.83%	57	62.86%
Dec 31, 2024	104	-43.48%	28,722,448	-65.13%	33	0.37%	68	-17.07%	14	-75.00%
Sep 30, 2024	183	2.23%	82,304,529	2.31%	94	1.03%	82	-2.38%	56	-9.68%
Jun 30, 2024	179	4.68%	80,450,005	-0.33%	95	1.04%	84	-11.58%	62	31.91%
Mar 31, 2024	171	20.42%	80,714,791	2.51%	96	0.93%	95	33.80%	47	9.30%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.75M	3.18%	-
Vanguard US Total Market Shares ETF	2.17M	2.68%	3.54K
iShares Russell 2000 ETF	1.92M	2.22%	939.00
SPDR® S&P Biotech ETF	1.48M	1.71%	1.91K
Vanguard Institutional Extnd Mkt Idx Tr	1.27M	1.47%	3.22K
HBM Healthcare Investments AG Ord	1.21M	1.40%	-
Fidelity Small Cap Index	723.17K	0.84%	13.98K
iShares Russell 2000 Growth ETF	641.80K	0.74%	-
Franklin Biotechnology Discv A(acc)USD	533.90K	0.62%	-
Candriam Eqs L Biotech C USD Cap	467.46K	0.60%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 19, 2025	Bair Teresa Brophy	Chief Legal Officer	Sell	$9.29K
May 19, 2025	FORD KATHLEEN	Chief Operating Officer	Sell	$9.78K
Mar 21, 2025	Hasnain Faheem	-	Sell	$181.46K
Jan 28, 2025	DOYLE THOMAS JAMES	SVP, Finance & Accounting	Sell	$6.98K
Jan 28, 2025	DOYLE THOMAS JAMES	SVP, Finance & Accounting	Sell	$5.50K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	2
2025 Q1	-	15
2024 Q4	-	1
2024 Q3	-	-
2024 Q2	-	1

KURA Ownership FAQ

Who Owns Kura Oncology?

Kura Oncology shareholders are primarily institutional investors at 92.04%, followed by 1.09% insiders and 6.87% retail investors. The average institutional ownership in Kura Oncology's industry, Biotech Stocks , is 63.96%, which Kura Oncology exceeds.

Who owns the most shares of Kura Oncology?

Kura Oncology’s largest shareholders are Blackrock funding, inc. /de (7.93M shares, 9.12%), Blackrock (6.97M shares, 8.30%), and Armistice capital (5.8M shares, 6.67%). Together, they hold 24.10% of Kura Oncology’s total shares outstanding.

Does Blackrock own Kura Oncology?

Yes, BlackRock owns 8.30% of Kura Oncology, totaling 6.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 143.43M$. In the last quarter, BlackRock increased its holdings by 66.44K shares, a 0.96% change.

Who is Kura Oncology’s biggest shareholder by percentage of total assets invested?

Foresite capital management iv is Kura Oncology’s biggest shareholder by percentage of total assets invested, with 13.82% of its assets in 1.73M Kura Oncology shares, valued at 15.04M$.

Who is the top mutual fund holder of Kura Oncology shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Kura Oncology shares, with 3.18% of its total shares outstanding invested in 2.75M Kura Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools